SAB Biotherapeutics- Warrants (25/07/2027) Operating Income

SAB Biotherapeutics- Warrants (25/07/2027) (SABSW) currently reports a operating income of $-72M as of June 2026. That compares with $-36M in the prior-year period — down 98.6% year over year. Use the charts on this page to explore SAB Biotherapeutics- Warrants (25/07/2027)'s operating income history and peer comparisons.

SAB Biotherapeutics- Warrants (25/07/2027)'s operating income decreased from $-36M to $-72M — a 98.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

SAB Biotherapeutics- Warrants (25/07/2027) reported $-72M in operating income as of June 2026. That compares with $-36M in the prior-year period — down 98.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-72M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for SAB Biotherapeutics- Warrants (25/07/2027), and consider following SABSW for alerts when major investors trade the stock.